Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07159061 · ClinicalTrials.gov registry record · NA
Neurofeedback to Treat Depression - 2
A NA study of Major Depressive Disorder (MDD), sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07159061 is a NA study of Major Depressive Disorder (MDD) that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 80 participants, below the 155-participant average among 22 other Major Depressive Disorder (MDD) trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07159061, a NA study of Major Depressive Disorder (MDD), is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.
Conditions Studied
Interventions
- BEHAVIORAL Active Closed Loop Real Time fMRI Neurofeedback
- BEHAVIORAL Sham Closed Loop Real Time fMRI Neurofeedback
Study Locations (1)
Pennsylvania
- Center for Neuromodulation in Depression and Stress - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07159061
The ClinicalTrials.gov registry entry for NCT07159061 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 22 other Major Depressive Disorder (MDD) trials with a reported enrollment target (48% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder (MDD) appearing as the primary indexed condition, and to 2 interventions - of which Active Closed Loop Real Time fMRI Neurofeedback is the first listed.
NCT07159061 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07159061 about?
NCT07159061 is a clinical study titled "Neurofeedback to Treat Depression - 2". This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamical...
What is the current status of trial NCT07159061?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-11-21. Estimated completion is 2028-12-01.
What conditions does trial NCT07159061 study?
This clinical trial studies the following conditions: Major Depressive Disorder (MDD).
What interventions are being tested in trial NCT07159061?
The interventions under investigation include: Active Closed Loop Real Time fMRI Neurofeedback (BEHAVIORAL), Sham Closed Loop Real Time fMRI Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT07159061?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07159061 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder (MDD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk
RECRUITING · NA
-
Home-Based tDCS Treatment Of Major Depressive Disorder
RECRUITING · NA
-
Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation
RECRUITING · NA
-
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
RECRUITING · NA
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.